Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 12:25 PM
Study NCT ID:
NCT07386002
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-10
First Post:
2026-01-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
Sponsor:
T-MAXIMUM Pharmaceutical Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-06-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12-13
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-27
First Submit QC Date:
None
Study First Post Date:
2026-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-06
Last Update Post Date:
2026-02-10
Last Update Post Date Type:
ACTUAL